MGMT and glioblastoma: Additionally, we evaluated molecular markers including MGMT (available for 84 subjects), and IDH (available for 128 subjects), as well as extent of resection (EOR) (available for 120 subjects) for prognosis of GBM survival (the status of the subjects for which the EOR and MGMT were available are provided in the supplementary document).